Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Education RFPsEducation Bids and Bidding Guide
More education bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Study for Dengue, Chikungunya, Zika, Hantaviruses…

U.S. Department Of Defense·Maryland

Study for Dengue, Chikungunya, Zika, Hantaviruses, Crimean-Congo Haemorrhagic Fever (CCHF)

Closes 5/10/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to the University of Colombo to conduct a study on acute undifferentiated febrile illness (AUFI) surveillance for dengue, chikungunya, Zika, hantaviruses, and Crimean-Congo hemorrhagic fever in Sri Lanka. The study aims to recruit a cohort of patients, collect clinical and environmental exposure data, and perform testing for AUFI pathogens. The contractor will be required to perform various tasks, including recruiting patients, collecting samples, and conducting molecular diagnostics. • The contractor will recruit a cohort of 150-200 patients hospitalized for AUFI in Eastern Province Sri Lanka. • The contractor will collect detailed clinical, occupational, and environmental exposure data to identify associated risk factors for identified AUFI pathogens. • The contractor will carry out testing for AUFI pathogens utilizing species-specific molecular diagnostics. • The contractor will perform genotyping on dengue and determine the strain of chikungunya virus on positive specimens.

Attached files

Contact

Shamai Carter

[email protected]

Key dates

Opened
5/5/2026
Closes
5/10/2026

Last updated

Details

Type
Sole Source
Industry
Education
NAICS
611310
Solicitation №
1301361960

Budget estimate

$100,000 – $500,000

The budget for this contract is not specified in the document. However, based on the scope of work, which includes recruiting patients, collecting samples, and conducting molecular diagnostics, the budget could be in the range of $100,000 to $500,000. The factors that may influence the likely payment range include the number of patients recruited, the complexity of the testing and diagnostics, and the duration of the study.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 68%

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027Opened 10/6/2026

U.S. National Institute of Food and Agriculture·United States of America

68% match

Emergency Citrus Disease Research and Extension Pre-Applications

Closes 11/2/2026Opened 9/2/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

68% match

National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers

Closes 6/30/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

67% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. Centers for Disease Control - NCHHSTP·United States of America

67% match

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Closes 6/22/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

67% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

67% match

Expanded Surveillance for Pediatric Infectious Diseases

Closes 1/29/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

67% match

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

67% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

67% match

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Closes 3/17/2027Opened 6/9/2026

U.S. Indian Health Service·United States of America

66% match

Tribal Epidemiology Centers

Closes 6/30/2027Opened 8/6/2026

U.S. National Institutes of Health·United States of America

66% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

66% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

66% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

U.S. Department Of Health And Human Services·Maryland

66% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

66% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

66% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

66% match

Health and Extreme Weather Solutions-Focused Research Hubs (U54 - Clinical Trial Optional)

Closes 1/28/2027Opened 6/26/2026

U.S. National Institutes of Health·United States of America

66% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

Hawaii Department of Health·Hawaii

66% match

2027 Proficiency Testing Panels

Closes 11/5/2026Opened 10/20/2026

U.S. National Institutes of Health·United States of America

66% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

Iowa State University·Iowa

65% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

65% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

65% match

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

Closes 11/10/2026Opened 3/10/2026

U.S. National Institutes of Health·United States of America

65% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025